Riskpilot← Back to searchSign inGet full accessFik Medical consult AB
ABActiveOrg 5592589286Mellanbyplan 12General medical practice activities · NACE 8621Est. 20200 employees
Revenue 2024
SEK 60K
-90% vs 2023
EBITDA margin
26.4%
+321% vs 2023
Equity ratio
83.9%
Financial strength
Net profit 2024
SEK 10K
+264% vs 2023
| Revenue | SEK 60K | -90% |
| EBITDA | SEK 16K | +321% |
| Net profit | SEK 10K | +264% |
| Total assets | SEK 79K | -74% |
| Equity | SEK 66K | +18% |
| Employees | 0 | — |
Legal name
Fik Medical consult AB
Org number
5592589286
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
9 juni 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget jobbar som medicinsk konsult inom häls-sjukvården i hela landet med privata och statliga sektor. Företaget säljer service och tjänst till olika häls-sjukvårdens sektor.Målet till företaget är att samla kompetenta häls- sjukvårdens personal bla läkare, sjuksköterska för att sälja deras tid(tjänst) till olika verksamhet inom häls-sjukvården, alltså kommer det att jobba som hyrläkare och sköterska.
Address
Mellanbyplan 12
Email
drsamatar@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 84 | 551 | 625 | 631 | 60 |
| Staff expenses | — | — | −660 | −532 | −6 |
| EBITDA | 11 | 173 | −109 | 4 | 16 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 11 | 173 | −109 | 4 | 16 |
| Net financials | — | — | 0 | −10 | −6 |
| Profit before tax | 11 | 173 | −109 | −6 | 10 |
| Tax | −2 | −36 | — | — | — |
| Net profit | 9 | 137 | −109 | −6 | 10 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 49 | 340 | 250 | 302 | 79 |
| Equity | 34 | 171 | 62 | 56 | 66 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 16 | 169 | 188 | 246 | 13 |
| Total debt | 16 | 169 | 188 | 246 | 13 |
EBITDA margin
26.4%
This company
15.8%
Market median
+67% vs market
20202024
Equity ratio
83.9%
This company
38.2%
Market median
+120% vs market
20202024
Return on equity
15.5%
This company
18.4%
Market median
+16% vs market
20202024
Net profit margin
17.1%
This company
8.1%
Market median
+111% vs market
20202024
Asset turnover
0.76×
This company
1.12×
Market median
-32% vs market
20202024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-06-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Fik Medical consult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Samatar Hassan Ismael Abdillahi | Board of Directors | 0 companies |
| Asma Mohamed | Deputy Board Member | 0 companies |